
Kyverna Therapeutics, Inc. (KYTX)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
10.74 - Open
10.72 - Bid 7.00 x 100
- Ask 12.03 x 100
- Day's Range
9.31 - 10.72 - 52 Week Range
2.06 - 13.67 - Volume
1,195,416 - Avg. Volume
884,519 - Market Cap (intraday)
576.947M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-3.27 - Earnings Date (est.) Aug 12, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
30.40
Recent News: KYTX
View MorePerformance Overview: KYTX
Trailing total returns as of 5/15/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: KYTX
View MoreAnalyst Insights: KYTX
View MoreStatistics: KYTX
View MoreValuation Measures
-
Market Cap
565.35M
-
Enterprise Value
315.13M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
2.43
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-39.55%
-
Return on Equity (ttm)
-74.55%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-156.4M
-
Diluted EPS (ttm)
-3.27
Balance Sheet and Cash Flow
-
Total Cash (mrq)
236.45M
-
Total Debt/Equity (mrq)
17.26%
-
Levered Free Cash Flow (ttm)
-94.77M
Compare To: KYTX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.




